Gupta Akhilesh, Kaur Ranvinder, Malhotra Rohit, Kale Suniti
Department of Anaesthesia, Safdarjang Hospital, Delhi, India.
Paediatr Anaesth. 2006 Apr;16(4):399-405. doi: 10.1111/j.1460-9592.2005.01783.x.
The aim of our study was to determine the optimal dose of propofol preceded by fentanyl for successful tracheal intubation and to see its effectiveness in blunting pressor response in children aged 3-10 years.
This prospective, double blind, randomized study was conducted on 60 ASA grade I and II children, between 3 and 10 years undergoing elective surgery who were divided into three groups of 20 each. The children received different doses of propofol (group I, 2.5 mg x kg(-1); group II, 3.0 mg x kg(-1); group III, 3.5 mg x kg(-1)) preceded by a fixed dose of fentanyl (3.0 microg x kg(-1)) 3 min earlier. The tracheal intubating conditions were graded based on scoring system devised by Helbo-Hensen et al. with Steyn modification which includes five criteria; ease of laryngoscopy, degree of coughing, position of vocal cords, jaw relaxation, and limb movement and graded on a 4-point scale. Heart rate (HR), mean arterial pressure (MAP), and oxygen saturation changes were also noted.
Tracheal intubating conditions were acceptable in 25% of the patients in group I, while significantly higher (P < 0.001) in group II (80%) and in group III (90%). The pressor response was not effectively blunted in group I (17% increase in HR), while effectively blunted in groups II and III. A fall in cardiac output was seen in group III indicated by a decrease in MAP (16%) and HR (11%). No airway complications were noted.
Propofol 3 mg x kg(-1) (group II) preceded by fentanyl 3 microg x kg(-1) is the optimal dose combination in our study. It provides acceptable intubating conditions in 80% patients, blunts pressor response to intubation without significant cardiovascular depression.
我们研究的目的是确定在芬太尼预处理后用于儿童成功气管插管的丙泊酚最佳剂量,并观察其对3至10岁儿童插管时升压反应的抑制效果。
本前瞻性、双盲、随机研究纳入了60例年龄在3至10岁、接受择期手术的ASA I级和II级儿童,将其分为三组,每组20例。儿童在提前3分钟给予固定剂量芬太尼(3.0微克/千克)后,接受不同剂量的丙泊酚(I组,2.5毫克/千克;II组,3.0毫克/千克;III组,3.5毫克/千克)。气管插管条件根据Helbo-Hensen等人设计并经Steyn修改的评分系统进行分级,该系统包括五个标准:喉镜检查的难易程度、咳嗽程度、声带位置、下颌松弛程度和肢体运动,并按4分制评分。同时记录心率(HR)、平均动脉压(MAP)和血氧饱和度的变化。
I组25%的患者气管插管条件可接受,而II组(80%)和III组(90%)显著更高(P<0.001)。I组的升压反应未得到有效抑制(HR增加17%),而II组和III组得到有效抑制。III组出现心输出量下降,表现为MAP(16%)和HR(11%)降低。未观察到气道并发症。
在我们的研究中,芬太尼3微克/千克预处理后给予丙泊酚3毫克/千克(II组)是最佳剂量组合。它能使80%的患者获得可接受的插管条件,抑制插管时的升压反应,且无明显心血管抑制。